Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/Amlodipine Fixed Combination in Uncontrolled Hypertension
NCT01241487Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan, amlodipine in primary hypertension, sponsored by Novartis. Started Feb 2009; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
primary hypertension
Beyond the preview
Go deeper on NCT01241487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01241487.